Twist Bioscience: Q4 Earnings Insights

 

Shares of Twist Bioscience TWST were unchanged after the company reported Q4 results.

Quarterly Results

Earnings per share increased 43.75% year over year to ($0.54), which beat the estimate of ($0.70).

Revenue of $32,432,000 rose by 106.10% year over year, which beat the estimate of $22,670,000.

Guidance

Twist Bioscience hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Details Of The Call

Date: Nov 23, 2020

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/jezd66vg

Price Action

Company's 52-week high was at $117.69

Company's 52-week low was at $18.52

Price action over last quarter: Up 87.41%

Company Description

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!